0001213900-21-058679 | 10-Q | XBRL Viewer | Health Sciences Acquisitions Corp 2

Private Placement (Details) $ in Millions	9 Months Ended
Sep. 30, 2021 USD ($) shares
Private Placement (Details) [Line Items]
Purchase price	$ 4.5
Private placement warrants, shares (in Shares) \| shares	1,500,000
Aggregate Price Paid	$ 1.5
Aggregate amount of private placement	6.0
Generating gross proceeds	$ 6.0

Ordinary Shares Subject to Possible Redemption (Details) - shares	Sep. 30, 2021	Dec. 31, 2020
Ordinary Shares Subject To Possible Redemption Disclosure [Abstract]
Ordinary shares outstanding	20,450,000
Shares subject to possible redemption	16,000,000	16,000,000

Initial Public Offering (Details) $ in Millions	Aug. 06, 2020 USD ($)
Initial Public Offering (Details) [Line Items]
Deferred underwriting commissions	$ 5.6

Ordinary Shares Subject to Possible Redemption (Details) - Schedule of condensed balance sheets is reconciled	9 Months Ended
	Sep. 30, 2021 USD ($)
Schedule of condensed balance sheets is reconciled [Abstract]
Gross proceeds received from Initial Public Offering	$ 160,000,000
Plus:
Ordinary shares subject to possible redemption	$ 160,000,000

Print Document View Excel Document
Notes Details Initial Public Offering (Details) Private Placement (Details) Ordinary Shares Subject to Possible Redemption (Details) Ordinary Shares Subject to Possible Redemption (Details) - Schedule of condensed balance sheets is reconciled Uncategorized Uncategorized Items - f10q0921_healthsciences_htm.xml All Reports

Label	Element	Value
DescriptionOfPrivatePlacementWarrant	hsaq_DescriptionOfPrivatePlacementWarrant	Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 450,000 ordinary shares (the “Private Placement Shares”), at a price of $10.00 per Private Placement Share to the Sponsor, (for a total purchase price of $4.5 million), and (ii) 1,500,000 warrants (“Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant (for a total purchase price of $1.5 million), generating gross proceeds to the Company of $6.0 million (Note 4).
NetGainFromInvestmentsHeldInTrustAccount	hsaq_NetGainFromInvestmentsHeldInTrustAccount	$ 4,034
NetGainFromInvestmentsHeldInTrustAccount	hsaq_NetGainFromInvestmentsHeldInTrustAccount	2,411
NetGainFromInvestmentsHeldInTrustAccount	hsaq_NetGainFromInvestmentsHeldInTrustAccount	11,969
NetGainFromInvestmentsHeldInTrustAccount	hsaq_NetGainFromInvestmentsHeldInTrustAccount	$ 2,411
WarrantsToPurchaseOrdinaryShares	hsaq_WarrantsToPurchaseOrdinaryShares	1,500,000
IssuanceOfOrdinarySharesToSponsor	hsaq_IssuanceOfOrdinarySharesToSponsor	$ 400
IssuanceOfOrdinarySharesToSponsor	hsaq_IssuanceOfOrdinarySharesToSponsor	28,350
IssuanceOfOrdinarySharesToSponsor	hsaq_IssuanceOfOrdinarySharesToSponsor	28,750
IssuanceOfOrdinarySharesToSponsor	hsaq_IssuanceOfOrdinarySharesToSponsor
ProceedsFromIssuanceOfPrivatePlacements	hsaq_ProceedsFromIssuanceOfPrivatePlacements	160,000,000
IncurredExpenses	hsaq_IncurredExpenses	30,000
IncurredExpenses	hsaq_IncurredExpenses	$ 90,000
StockholdersEquityDescription	hsaq_StockholdersEquityDescription	the Company effected a share dividend of 0.113043478 ordinary shares for each outstanding share (an aggregate of 406,250 ordinary shares), resulting in an aggregate of 4,000,000 ordinary shares outstanding. All ordinary shares and associated amounts have been retroactively restated to reflect the share dividend. Of the 4,000,000 ordinary shares outstanding, up to 521,739 of these ordinary shares was subject to forfeiture by the Sponsor (or its permitted transferees) on a pro rata basis depending on the extent to which the underwriters’ over-allotment option was exercised.
WorkingCapitalAmount	hsaq_WorkingCapitalAmount	$ 1,700,000
ProceedFromIssuanceInitialPublicOffering	hsaq_ProceedFromIssuanceInitialPublicOffering	160,000,000
ProceedFromIssuanceInitialPublicOffering	hsaq_ProceedFromIssuanceInitialPublicOffering	521,739
ProceedFromIssuanceOfCommonStock	hsaq_ProceedFromIssuanceOfCommonStock	$ 28,750
AccruedExpensesRelatedPartyOutstanding	hsaq_AccruedExpensesRelatedPartyOutstanding	120,000
AccruedExpensesRelatedPartyOutstanding	hsaq_AccruedExpensesRelatedPartyOutstanding	30,000
DeferredUnderwritingCommissionsInConnectionWithTheInitialPublicOffering1	hsaq_DeferredUnderwritingCommissionsInConnectionWithTheInitialPublicOffering1	5,600,000
DeferredUnderwritingCommissionsInConnectionWithTheInitialPublicOffering1	hsaq_DeferredUnderwritingCommissionsInConnectionWithTheInitialPublicOffering1
AggregatePurchasePrice	hsaq_AggregatePurchasePrice	25,000,000
DeferredUnderwritingCommission	hsaq_DeferredUnderwritingCommission	5,600,000
DeferredUnderwritingCommission	hsaq_DeferredUnderwritingCommission	5,600,000
LoanAmount	hsaq_LoanAmount	300,000
DeferredUnderwritingCommissionsInConnectionWithTheInitialPublicOffering	hsaq_DeferredUnderwritingCommissionsInConnectionWithTheInitialPublicOffering	5,600,000
DeferredUnderwritingCommissionsInConnectionWithTheInitialPublicOffering	hsaq_DeferredUnderwritingCommissionsInConnectionWithTheInitialPublicOffering	$ 5,600,000
SubjectToForfeitureShares	hsaq_SubjectToForfeitureShares	521,739
PublicPerSharePrice	hsaq_PublicPerSharePrice	10
WarrantsDescription	hsaq_WarrantsDescription	Each warrant is exercisable to purchase one of ordinary shares at an exercise price of $11.50 per full share and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.
AggregatePurchaseToOrdinaryShares	hsaq_AggregatePurchaseToOrdinaryShares	2,500,000
IssuanceOfPublicSharesUnderOverallotment	hsaq_IssuanceOfPublicSharesUnderOverallotment	2,086,956
ShareOutstanding	hsaq_ShareOutstanding	406,250
AccruedExpensesRelatedParty	hsaq_AccruedExpensesRelatedParty	$ 120,000
AccruedExpensesRelatedParty	hsaq_AccruedExpensesRelatedParty	30,000
BorrowedAmount	hsaq_BorrowedAmount	$ 300,000
UnderwritingAgreementDescription	hsaq_UnderwritingAgreementDescription	The Company granted the underwriters a 45-day option from the date of this prospectus to purchase up to 2,086,956 additional Ordinary Shares at the Initial Public Offering price less the underwriting discounts and commissions.
IssuanceOfOrdinarySharesToSponsorinShares	hsaq_IssuanceOfOrdinarySharesToSponsorinShares	4,000,000